Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

synthetic psilocybin

Mindset Pharma (MSET.C) announced that they have filed an international patent for their novel psilocybin synthesis method. The application covers Mindset’s Synthesis Process, a process they call “ground-breaking” and…
There are two options when it comes to ingesting psychedelics, natural or synthetic.   People have been tripping balls eating raw natural mushrooms for thousands of years, so why…
Core One Labs (COOL.C) subsidiary Vocan Biotechnologies finished putting together the required equipment to start artificially producing psilocybin today, according to a press release. Acquired in December, Vocan has…
Core One’s objective in developing the psilocybin thinstrips is to assist with the delivery of revolutionary psychedelic treatment methods to address mental health conditions such as depression, anxiety and…
“This transaction will significantly enhance Core One Labs’ ability to innovate our psychedelic drug development program,” stated Joel Shacker, CEO of Core Labs….